Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says
Incyte's (INCY) colorectal cancer or CRC programs remain "risky and more long-term," RBC Capital Mar
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo